Best Probiotics for Gas and Bloating: Evidence-Based Strains That Actually Work
What the peer-reviewed clinical research says about probiotics for intestinal gas, flatulence, and abdominal bloating—and which strains have the most evidence
Gas. Bloating. Flatulence. The terms might draw uncomfortable laughs, but for the millions of people who deal with chronic abdominal discomfort, distension, and excessive intestinal gas, there's nothing funny about it. Whether it surfaces after meals, derails social plans, or is simply a persistent source of daily discomfort, the root cause almost always traces back to the same place: the gut microbiome.
Probiotics have emerged as one of the most researched interventions for gas and bloating, and the evidence behind specific strains is considerably more specific than most general "gut health" marketing would suggest. A 2025 umbrella meta-analysis spanning research through June 2024 found that probiotic supplementation was associated with a statistically significant 26% reduction in the risk of bloating compared to placebo, with multi-strain formulations showing particularly pronounced effects.[1]
But not all probiotics work the same way, and strain selection matters enormously. This guide examines the peer-reviewed clinical evidence behind specific probiotic strains for managing intestinal gas and bloating—focusing on strains with the strongest research support and the clearest mechanisms of action.
If you're already familiar with the basics and looking for targeted strain guidance for related digestive issues, our evidence-based guide to probiotics for bloating and our overview of probiotics for smelly gas go deeper on specific sub-topics. For context on how the microbiome gets disrupted in the first place, our guide to dysbiosis covers the foundational mechanisms.
Key Takeaways
- Probiotics reduce bloating risk by 26% versus placebo according to a 2025 umbrella meta-analysis of clinical trials, with the strongest effects seen in multi-strain formulations and shorter intervention windows.[1]
- Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 produced significant improvements in bloating severity compared to placebo at both 4 and 8 weeks in a double-blind RCT of patients with functional bowel disorders.[2]
- Lactobacillus plantarum 299v produced significant reductions in flatulence and bloating in a double-blind, placebo-controlled trial of 214 IBS patients meeting Rome III criteria.[3]
- Bacillus coagulans MTCC 5856 significantly reduced gas, bloating, burping, and flatulence scores versus placebo in a multicenter randomized controlled trial of adults with functional gas and bloating.[4]
- A multi-strain synbiotic containing L. rhamnosus, L. acidophilus, B. lactis, B. longum, and B. bifidum significantly reduced flatulence and IBS symptom severity compared to placebo in a double-blind RCT.[5]
- The microbiome composition directly determines gas output—lower Bifidobacterium and Lactobacillus populations, paired with elevated Clostridia and Bacteroidetes, are consistently found in patients with functional bloating and distension.[6]
Why Intestinal Gas and Bloating Happen
Before understanding how probiotics help, it's worth understanding the mechanism behind the discomfort. Intestinal gas is a normal byproduct of digestion—but when production outpaces transit, or when the gut's microbial balance tips in the wrong direction, that normal process becomes a daily source of distress.
The Fermentation Process
When you eat carbohydrates that aren't fully digested in the small intestine—things like certain fibers, oligosaccharides, and, for some people, lactose—those molecules reach the colon largely intact. There, they become fuel for the trillions of bacteria that colonize the large intestine. The fermentation that follows is productive in many ways: it generates short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate that nourish the gut lining and support immune function. But fermentation also produces gas—predominantly hydrogen (H₂), carbon dioxide (CO₂), and in some people, methane (CH₄).

A comprehensive review of intestinal gas production published in 2022 found that more than 99% of intestinal gas volume is composed of these three gases, with the remaining less than 1% comprised of sulfur-containing compounds responsible for odor.[7] The review identified that specific genera—including Ruminococcus, Clostridium, Eubacterium, and Methanobrevibacter—are among the primary gas-producing microbes, and that foods rich in raffinose family oligosaccharides, fructans, and polyols consistently drive elevated gas output.
Methane, Motility, and Constipation-Type Bloating
Gas type matters. Methane production in the gut has been specifically linked to slowed intestinal transit—a key driver of the distension and bloating that often accompanies constipation-predominant symptoms. Research on intestinal gas and gut motility found that methane infusion decreased peristaltic velocity and increased contraction amplitude in the ileum, while hydrogen was associated with shortened colonic transit time.[8] This means that the microbial balance influencing which gases predominate can also directly affect how quickly—or slowly—contents move through the gut, compounding bloating when methane-producing archaea are overrepresented.
Common Triggers That Amplify Gas Production
Certain dietary patterns reliably increase gas output by providing more fermentable substrate to colonic bacteria. Pulses (beans, lentils, chickpeas), cruciferous vegetables, onions, garlic, wheat, and some fruits top the list. For people with lactose intolerance, dairy products contribute substantially. Small intestinal bacterial overgrowth (SIBO) represents a more serious end of the spectrum, where bacteria that don't normally colonize the upper digestive tract proliferate there and ferment carbohydrates before they even reach the colon—causing gas symptoms that tend to begin within minutes of eating rather than hours later.
Stress, antibiotic use, and disrupted gut microbiome diversity all amplify gas symptoms by shifting the microbial landscape toward more gas-producing species—which brings us to the central role the microbiome plays in gas regulation.
The Microbiome–Gas Connection: What Goes Wrong
The type and volume of gas your gut produces isn't determined solely by what you eat—it's determined by which microbes are present to ferment it. Two people eating identical meals can have dramatically different gas outcomes based on their microbiome composition. This individual variation is one reason that symptom management through probiotics requires strain-level specificity: you're targeting a microbial ecosystem, not just a symptom.

The Dysbiosis–Bloating Link
Studies examining the gut microbiota of individuals with functional abdominal bloating and distension consistently find the same pattern: reduced microbial diversity, lower abundance of Bifidobacterium and Lactobacillus, and elevated levels of Bacteroidetes and Clostridia. These shifts disrupt intestinal neuromuscular function, compromise mucosal barrier integrity, and alter the immune response in the gut wall—all of which contribute to the perception of bloating even when gas volumes may not differ dramatically from healthy controls.[6]
The practical implication: replenishing Bifidobacterium and Lactobacillus populations addresses the microbiome imbalance that permits excessive or misdistributed gas in the first place. This is why the most clinically effective probiotics for gas are those that directly target the genera consistently found to be deficient in symptomatic individuals. For a deeper look at what deficiency in these populations looks like and how it manifests as symptoms, see our guides to Lactobacillus deficiency and Bifidobacterium deficiency.
The IBS–Gas Overlap
For many people, gas and bloating are the primary symptoms of irritable bowel syndrome (IBS)—a condition affecting roughly 10–15% of adults globally and characterized by altered gut motility, visceral hypersensitivity, and, critically, microbiome disruption. Most of the rigorous probiotic clinical trials targeting gas and bloating have been conducted in IBS populations, which is why the evidence base in this area is closely tied to IBS research. The good news: the mechanisms that drive gas and bloating in IBS are the same fermentation-dysbiosis mechanisms that drive symptoms in people without a formal IBS diagnosis, meaning the clinical findings are broadly applicable. Our full breakdown of the best probiotics for IBS covers the complete IBS evidence landscape if you want more detail.
How Probiotics Reduce Gas and Bloating: The Mechanisms
Probiotics don't simply suppress gas production by some generic effect on the gut. The mechanisms through which specific strains reduce gas-related symptoms are diverse, and understanding them helps explain why certain strains work better than others for this particular issue.
Competitive Exclusion of Gas-Producing Bacteria
By colonizing niches in the gut and producing antimicrobial substances like bacteriocins and lactic acid, beneficial probiotic bacteria—particularly Lactobacillus and Bifidobacterium species—compete directly with gas-producing bacteria for space and fermentable substrate. When beneficial populations are robust, the more gas-producing Clostridia and fermentative proteobacteria have less room and less fuel to proliferate.
Modulation of Fermentation Pathways
Specific probiotic strains shift the fermentation balance toward acetate and lactate production rather than hydrogen and methane. This is partly a function of which microbes dominate fermentation of a given substrate—and Lactobacillus species in particular tend to produce a fermentation profile that favors lower gas output. Research on short-chain fatty acid production confirms that a Lactobacillus-and-Bifidobacterium-dominated microbiome tilts SCFA output in ways that support gut wall integrity rather than pathological fermentation.

Intestinal Motility and Transit Regulation
Some probiotic strains—particularly L. plantarum—appear to normalize intestinal transit in both directions: accelerating transit in constipation-predominant presentations while moderating it in diarrhea-predominant cases. Normalized transit means gas doesn't accumulate as long in the colon, reducing distension and the perception of bloating.
Visceral Sensitivity Reduction
Research on Lactobacillus acidophilus NCFM has shown that this strain modulates colonic mucosal opioid receptor expression—a pathway involved in visceral pain perception. Reducing the gut's sensitivity to its own gas volumes is distinct from reducing gas production: some individuals with functional bloating have normal gas amounts but heightened sensitivity to them. By modulating pain signaling pathways, certain probiotic strains reduce the symptomatic burden of gas even when total volume doesn't change dramatically.
Barrier Integrity and Mucosal Support
A compromised intestinal barrier allows bacterial products and gas to distribute abnormally, contributing to the sensation of bloating even when luminal gas volumes are not elevated. Probiotic strains that strengthen tight junction proteins and support the mucus layer—particularly L. plantarum and B. longum—help normalize the gut's physical architecture in ways that reduce bloating as a secondary benefit. See our article on probiotics for intestinal barrier repair for the research on this mechanism.
Best Probiotic Strains for Gas and Bloating: The Clinical Evidence
What follows is a review of the probiotic strains with the most direct clinical evidence for reducing intestinal gas, flatulence, and bloating—organized by the strength and specificity of the research.
Lactobacillus acidophilus + Bifidobacterium lactis: The Most Studied Combination
The most rigorously studied combination specifically for bloating involves Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07. In a double-blind, placebo-controlled clinical trial enrolling 60 subjects with functional bowel disorders (including IBS and functional bloating), participants who received this probiotic blend twice daily experienced significantly improved bloating severity compared to the placebo group at 4 weeks (p=0.009) and 8 weeks (p<0.01). The probiotic group's bloating scores were notably lower than the placebo group at both measurement points, making this one of the clearest head-to-head demonstrations of probiotic benefit for this specific symptom.[2]
A separate investigation also found that L. acidophilus NCFM modulates colonic mucosal opioid receptor expression in humans with functional abdominal pain—a pathway that helps explain why this strain reduces symptom perception even when gas volumes themselves may not change substantially.[10] For a comprehensive look at what this strain does across health applications, see our article on Lactobacillus acidophilus dosage and clinical guidelines.
Lactobacillus plantarum: Flatulence Reduction with IBS Evidence
Lactobacillus plantarum 299v is among the best-studied probiotic strains for IBS-related symptoms, and its effects on flatulence are particularly well-documented. In a multicenter, double-blind, placebo-controlled trial of 214 IBS patients fulfilling Rome III criteria, participants receiving L. plantarum 299v for 4 weeks showed significant reductions in both bloating severity and daily frequency compared to placebo (p<0.05 for both measures). At 4 weeks, 78.1% of patients in the L. plantarum group rated the treatment effect as excellent or good, compared to just 8.1% in the placebo group (p<0.01).[3]
An earlier placebo-controlled crossover trial specifically measured colonic fermentation using 24-hour indirect calorimetry and found that L. plantarum 299v reduced gas production objectively—not just symptom scores—and significantly lowered the composite symptom score in IBS patients.[11] For a deeper dive into what this strain does beyond gas relief, our article on Lactobacillus plantarum health benefits covers the full research picture.
Bacillus coagulans: Purpose-Built for Gas and Flatulence
Bacillus coagulans is arguably the strain with the most direct clinical evidence for functional gas relief in healthy adults without a formal IBS diagnosis. In a multicenter, randomized, double-blind, placebo-controlled trial specifically enrolling 70 adults with functional gas and bloating—scored by the validated Gastrointestinal Symptom Rating Scale (GSRS)—participants receiving B. coagulans MTCC 5856 (2 billion spores/day) for 4 weeks experienced dramatic reductions in the GSRS indigestion subscale, which includes abdominal distension, burping, borborygmi, and flatulence. The mean change from baseline was −5.85 in the B. coagulans group compared to −1.09 in placebo (p<0.001). Bloating scores dropped from 3.28 to 1.09 in the probiotic group, compared to no significant change in the placebo group (p=0.003). Flatus scores also declined significantly with the active treatment.[4]
A separate randomized, double-blind, placebo-controlled trial in 61 adults with post-prandial intestinal gas symptoms (abdominal pain, distention, flatulence) but no formal GI diagnoses found that B. coagulans GBI-30, 6086 improved quality of life and reduced gastrointestinal gas symptoms compared to placebo over a 4-week period—one of the few trials targeting this symptom profile in otherwise-healthy individuals.[12]
The spore-forming nature of Bacillus coagulans is particularly relevant here: it survives stomach acid and reaches the colon in viable, active form at higher rates than many non-spore-forming strains, which may explain its consistently strong showing in gas-related clinical trials. You can explore the full evidence base in our article on Bacillus coagulans benefits.
Bifidobacterium longum + Lactobacillus rhamnosus: Bloating and Microbiome Restoration
The combination of Bifidobacterium longum and Lactobacillus rhamnosus has been studied in the context of functional GI symptoms where gas and bloating persist despite dietary management. In a crossover, randomized, double-blind study of 23 patients with lactose intolerance and persisting functional GI symptoms on a lactose-free diet, 30 days of treatment with B. longum BB536 and L. rhamnosus HN001 significantly decreased bloating (p=0.028) compared to placebo, alongside positive shifts in intestinal microbial composition—increasing beneficial Lactobacillus, Bifidobacterium, and Faecalibacterium while reducing potentially harmful Enterobacteriaceae.[13]
A separate RCT in IBS patients specifically using B. longum BB536 and L. rhamnosus HN001 found improvements in IBS symptoms, intestinal permeability, and gut microbiota composition in treated patients versus placebo controls.[14] Our article on Lactobacillus rhamnosus benefits covers the broader clinical applications of this well-researched strain.
The Multi-Strain Synbiotic Advantage: Flatulence in IBS-D
A rigorous double-blind, randomized, placebo-controlled trial evaluated a multi-strain synbiotic containing Lactobacillus rhamnosus, Lactobacillus acidophilus, Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium bifidum, and prebiotic fructooligosaccharides in 68 adults with diarrhea-dominant IBS. The synbiotic group showed significantly greater improvements across symptom domains including flatulence, abdominal pain, stool pressure, and bowel habit compared to placebo at both 4 and 8 weeks.[5] The breadth of coverage—spanning multiple Lactobacillus and Bifidobacterium species simultaneously—likely explains why the combination outperformed what any single strain might achieve.

All of These Strains—In One Filler-Free Formula
MicroBiome Restore contains every strain discussed—L. acidophilus, B. lactis, L. plantarum, B. coagulans, B. longum, L. rhamnosus, B. bifidum—plus 19 additional evidence-backed strains. 26 strains total. 15 billion CFU. No microcrystalline cellulose. No magnesium stearate. No titanium dioxide.
Strain Evidence Summary
| Strain | Evidence for Gas/Bloating | Key Study Findings |
|---|---|---|
| L. acidophilus + B. lactis | Bloating reduction at 4 & 8 weeks | Significant improvement vs. placebo in double-blind RCT of FBD patients[2] |
| L. plantarum 299v | Flatulence & bloating reduction | 78.1% rated excellent/good response vs. 8.1% placebo; reduced colonic gas production[3] |
| B. coagulans MTCC 5856 | Gas, bloating, flatulence, burping | GSRS mean change −5.85 vs. −1.09 placebo (p<0.001) in functional gas adults[4] |
| B. longum + L. rhamnosus | Bloating reduction | Significant bloating decrease (p=0.028) in crossover RCT with microbiome improvement[13] |
| B. bifidum, B. longum, L. acidophilus | Abdominal pain, flatulence | Lower pain scores than placebo in meta-analysis; flatulence declined with all probiotic types tested[15] |
| Multi-strain synbiotic (L. rhamnosus, L. acidophilus, B. lactis, B. longum, B. bifidum) | Flatulence, overall IBS-D symptoms | Significant improvement in flatulence and symptom severity vs. placebo at 4 & 8 weeks[5] |
Why Multi-Strain Formulas Work Better for Gas Relief
One of the clearest patterns across the probiotics-for-gas literature is that multi-strain formulations tend to outperform single-strain approaches. The 2025 umbrella meta-analysis found more pronounced effects on gastrointestinal symptoms specifically from multi-strain formulations, particularly for symptom relief over shorter intervention periods.[1] A 2025 systematic review and meta-analysis noted that a 24-strain synbiotic produced significant improvements in bloating, gas, and abdominal discomfort, explicitly attributing the breadth of effect to broader microbial diversity coverage.[16]
The mechanistic reasoning is straightforward. Gas and bloating aren't caused by a single microbial imbalance—they involve the interplay of multiple bacterial species, fermentation pathways, motility mechanisms, and gut-brain signaling routes. A formula covering both Lactobacillus species (which target small intestinal fermentation balance, visceral sensitivity, and transit) and Bifidobacterium species (which compete with gas-producing Clostridia in the colon, ferment fiber through less gassy pathways, and restore microbial diversity) addresses more of the causal chain than any single strain can.
Including Bacillus species alongside Lactobacillus and Bifidobacterium further extends coverage. Bacillus coagulans—a spore-former capable of surviving stomach acid at higher rates—delivers active fermentation-modulating bacteria to the colon reliably, complementing the more acid-sensitive Lactobacillus and Bifidobacterium species. Our complete guide to single-strain vs. multi-strain probiotics covers this evidence in detail.
What About the "More Strains = More Gas" Concern?
A common worry about starting a high-strain probiotic is that it will initially worsen gas before it helps. This can happen in the first week or two—particularly if the microbiome is significantly imbalanced—as the incoming bacterial populations compete with established gas-producing species. This transition period, sometimes called the "die-off" phase, reflects ecological disruption in the gut microbiome rather than a sign the product isn't working. Clinical trials of multi-strain formulas consistently report that initial adjustment symptoms resolve and are followed by meaningful improvement. If you experience this, our guide to why probiotics may initially increase gut symptoms explains what's happening and what to expect.
What to Look for in a Probiotic for Gas and Bloating
Most probiotic marketing focuses on CFU count or the number of strains as the primary quality indicator. While both matter, they're far from the whole picture—especially when gas and bloating are the primary concern.
Strain Specificity: Genus and Species Aren't Enough
Clinical evidence in the probiotic field is strain-specific, meaning that the findings for Lactobacillus acidophilus NCFM don't automatically apply to every other L. acidophilus product on the shelf. When evaluating a probiotic for gas, look for formulas that include the specific strains with gas/bloating evidence: L. acidophilus, L. plantarum, B. lactis, B. longum, B. bifidum, and Bacillus coagulans are the best-supported options. Our article on the top probiotic strains for gut health provides a broader reference for strain selection.
Formulation Quality: What Else Is in the Capsule
Many commercial probiotics contain excipients and fillers that may actively undermine the gut health you're trying to support. Microcrystalline cellulose (MCC) is the most common—it's frequently used as a filler and flow agent but has shown potential adverse effects on gut microbiome composition in emerging research. Magnesium stearate and titanium dioxide are similarly prevalent and similarly worth avoiding in a product you're specifically taking to support gut microbial health.
Capsule material also matters. Pullulan capsules—made from fermented tapioca—provide delayed-release protection and are prebiotic by nature, contrasting favorably with HPMC (hypromellose) capsules. Look for filler-free labels that disclose all ingredients transparently. Our guide to reading supplement labels for hidden fillers provides a practical checklist.
Prebiotic Co-Formulation
A probiotic formula that includes prebiotic fiber can provide measurably better outcomes because the prebiotics serve as selective food for the beneficial bacteria being introduced. Acacia fiber, for instance, has a particularly strong track record for supporting Bifidobacterium and Lactobacillus populations without aggravating gas symptoms—a meaningful distinction given that some prebiotics (particularly inulin at high doses) can temporarily worsen gas before it improves. Our article on acacia fiber for sensitive guts covers this in detail. Jerusalem artichoke (a rich source of inulin), maitake mushroom, and bladderwrack are additional prebiotic sources that support microbiome restoration through complementary pathways.
CFU Count: Why 15 Billion Is the Practical Target
Clinical trials showing meaningful gas and bloating improvements have used doses typically in the range of 1–10 billion CFU per strain. In multi-strain formulas, a total of 10–15 billion CFU per serving covers the therapeutic range across multiple species without excessive dosing that may itself cause transitional discomfort. Higher isn't always better—what matters is that each individual strain is present in sufficient quantity to colonize meaningfully, and that total CFU is distributed across the strain profile rather than concentrated in a single dominant species.

Quick Checklist: Probiotic Quality for Gas Relief
Look for: Multiple Lactobacillus and Bifidobacterium strains; Bacillus coagulans; filler-free formulation; pullulan or enteric capsule; included prebiotics; 10–15+ billion CFU total.
Avoid: Microcrystalline cellulose, magnesium stearate, titanium dioxide, silicon dioxide as fillers; proprietary blends that hide individual strain amounts; single-strain formulas for complex gas symptoms; products without transparent ingredient disclosure.
MicroBiome Restore: Designed Around These Exact Principles
MicroBiome Restore from BioPhysics Essentials contains 26 probiotic strains including every gas-relevant strain discussed in this article, delivered at 15 billion CFU in a filler-free pullulan capsule. The formula includes 7 certified organic prebiotic sources—Jerusalem artichoke, maitake mushroom, acacia fiber, fig fruit, bladderwrack, Norwegian kelp, and oarweed—to support the strains you're introducing. Zero microcrystalline cellulose. Zero magnesium stearate. Zero titanium dioxide. Maltodextrin is included solely as a cryoprotectant to maintain strain viability during shelf storage—not as a filler. Read the complete MicroBiome Restore guide to understand how every ingredient was chosen.
When and How to Take Probiotics for Gas: Practical Guidance
Timing and consistency have a meaningful impact on probiotic effectiveness. The clinical trials showing the most significant gas and bloating improvements have generally used protocols with daily supplementation for 4–8 weeks, which reflects the time required for meaningful shifts in microbiome composition rather than a quick symptomatic fix.
The Best Time to Take Probiotics for Gas Relief
For gas and bloating specifically, taking probiotics with or shortly before a meal tends to improve survivability—the food provides buffering against stomach acid and gives the bacteria a more hospitable transit environment. Some strains, like Bacillus coagulans, are spore-formers that tolerate gastric acid well regardless of meal timing, but for Lactobacillus and Bifidobacterium species, the peri-meal window is generally preferred. Our comprehensive guide to the best time to take probiotics according to science covers the research in full, including timing nuances for different strain types.
How Long Before You See Results
Clinical trial data suggests most people begin to notice symptom improvement within 2–4 weeks of consistent supplementation, with the most significant changes typically measured at the 4-week and 8-week marks. If you're taking a multi-strain formula after a period of antibiotic use or significant microbiome disruption, the full recovery arc may take longer—our guide to probiotics after antibiotics addresses the extended timeline in that context. Consistency matters more than timing precision: taking your probiotic at the same time each day supports microbiome stability and makes adherence easier to maintain.

Dietary Adjustments That Work Alongside Probiotics
Probiotics work best when the dietary environment supports beneficial bacteria rather than actively fueling gas-producing species. During the initial weeks of probiotic supplementation, temporarily reducing high-FODMAP foods (high-fermentable-carbohydrate foods that feed gas producers most aggressively), increasing prebiotic fiber intake from cooked vegetables and legumes, and staying well-hydrated all complement the probiotic's work. This doesn't mean eliminating high-fiber or high-FODMAP foods permanently—in fact, long-term prebiotic fiber intake supports the Bifidobacterium populations that probiotics work to restore. The goal is to reduce the fermentative load during the initial transition period.
When Gas and Bloating May Signal Something More Serious
Probiotics are appropriate for functional gas and bloating—the kind driven by microbiome imbalance, diet, IBS, or general digestive sensitivity. If you experience gas and bloating accompanied by unintended weight loss, blood in stool, persistent severe pain, or symptoms that have changed significantly in character or intensity, these warrant evaluation by a healthcare provider to rule out conditions like inflammatory bowel disease, celiac disease, colon cancer, or structural GI issues before attributing symptoms to functional causes. Similarly, if you have SIBO, the approach to probiotic supplementation may need to be more targeted and carefully timed—see our guide to probiotics for SIBO for the nuances.
Frequently Asked Questions
Can probiotics make gas worse before it gets better?
Yes—and this is actually a well-recognized and clinically documented pattern, not a sign that the probiotic is failing. When a high-diversity probiotic formula introduces large populations of beneficial bacteria into a dysbiotic gut, there's an ecological competition period as beneficial species displace established gas-producing bacteria. This "adjustment phase" typically lasts 1–2 weeks and may involve temporarily increased gas, bloating, or changes in stool consistency. Clinical trial data shows that this transition resolves and is followed by meaningful improvement in the vast majority of cases. Starting with a lower dose and gradually increasing over 2 weeks can mitigate transitional symptoms. See our full explanation of why probiotics may temporarily increase gut symptoms.
Is there a difference between probiotics for gas and probiotics for bloating?
Gas and bloating are related but distinct symptoms, and the same strains tend to address both because they share the same root cause: microbial imbalance and abnormal fermentation. However, bloating without excess gas can also reflect visceral hypersensitivity—the gut perceiving normal amounts of gas as uncomfortable. Strains like L. acidophilus that modulate opioid receptor expression in the gut wall help with this component specifically, making them particularly relevant when bloating is disproportionate to audible gas. The Bacillus coagulans clinical trials enrolled patients specifically with gas symptoms; the L. acidophilus/B. lactis trials targeted functional bloating. Both symptom types respond to the same multi-strain approach.
What is the best probiotic for gas after antibiotics?
Antibiotic-associated gas and bloating typically reflect the dysbiosis that occurs when antibiotics disrupt the normal gut flora and create space for gas-producing species—particularly Clostridia and Proteobacteria—to overgrow. In this context, prioritizing multi-strain formulas that include both Lactobacillus and Bifidobacterium species helps restore the populations most depleted by antibiotics. Bacillus coagulans is particularly useful post-antibiotics because its spore-forming nature allows it to survive gastric transit reliably even when the gut environment has been disturbed. Our full probiotics after antibiotics guide covers the strain-by-strain evidence for microbiome recovery.
How long should I take probiotics for gas relief?
Clinical trials demonstrating meaningful gas and bloating improvements have used protocols of 4–8 weeks, which is the minimum window needed for microbiome composition to shift meaningfully. For ongoing functional GI symptoms driven by chronic microbiome imbalance, longer-term supplementation provides sustained benefit by maintaining the beneficial bacterial populations that suppress gas-producing species. Most people find that taking a comprehensive multi-strain probiotic daily becomes part of a general digestive wellness routine rather than a time-limited intervention, particularly if diet, stress, or periodic antibiotic use create recurring disruptions to their microbiome.
Can probiotics help with gas related to IBS?
Yes—this is actually where much of the strongest clinical evidence exists. An 82-trial systematic review and meta-analysis published in Gastroenterology in 2023, the largest to date on probiotics in IBS, identified meaningful evidence for benefit across multiple probiotic types, with certain strains showing moderate-to-high certainty evidence for global symptom improvement including bloating and flatulence.[9] The specific evidence for individual strains is reviewed in detail in our probiotics for IBS article. For IBS-D specifically, the synbiotic combination of multiple Lactobacillus and Bifidobacterium strains plus prebiotics showed strong benefits for flatulence and overall symptom burden in a recent RCT.[5]
Do prebiotics help with gas, or do they make it worse?
This is a nuanced question. At high doses, certain prebiotics—particularly inulin and other fructooligosaccharides—can temporarily worsen gas because they're rapidly fermented by all gut bacteria, including gas-producing ones. However, lower doses of prebiotics that selectively feed beneficial bacteria (like acacia fiber, which preferentially stimulates Bifidobacterium and Lactobacillus) tend to support the very microbial populations that reduce gas over time. The key is selecting prebiotic sources and doses that are well-tolerated rather than broadly fermentable at high rates. When prebiotics are co-formulated with probiotic strains as synbiotics, the synergistic effect—prebiotics selectively feeding the bacteria being introduced—typically outweighs any short-term fermentation increase.
The Bottom Line: Targeted Strains Make the Difference
The research on probiotics for gas and bloating is more specific than the general gut health category would suggest. Not every probiotic reduces flatulence—but several strains, studied in rigorous double-blind, placebo-controlled trials, show consistent, meaningful reductions in gas volume, bloating severity, flatulence frequency, and the functional discomfort associated with excess intestinal fermentation.
The evidence converges on a consistent principle: multi-strain formulas covering both Lactobacillus and Bifidobacterium genera—alongside spore-forming Bacillus species—produce the broadest relief by addressing multiple drivers of the gas-dysbiosis cycle simultaneously. Formulation quality matters just as much as strain selection: fillers that disrupt the very microbiome you're trying to restore undercut the clinical purpose of supplementation. And consistency over a minimum of 4 weeks is essential for the microbiome shifts that produce meaningful, durable symptom improvement.
For a complete picture of which ingredients do and don't belong in a gut health formula, the truth about flow agents and fillers is a useful companion read. And if you want to understand why the strain list you select matters more than the brand name on the label, our guide to probiotic strains, benefits, and best combinations provides a comprehensive reference.
26 Evidence-Backed Strains. Zero Fillers. One Daily Capsule.
MicroBiome Restore was formulated with a singular philosophy: every ingredient earns its place through peer-reviewed evidence, not manufacturing convenience. It includes every strain reviewed in this article—plus 19 more—alongside 7 certified organic prebiotic sources, in a filler-free pullulan capsule with 15 billion CFU per serving.
References
- Shirbeigi, L., et al. (2025). Probiotics and gastrointestinal disorders: an umbrella meta-analysis of therapeutic efficacy. European Journal of Medical Research, 30(1). https://doi.org/10.1186/s40001-025-02788-w
- Ringel-Kulka, T., Palsson, O. S., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., & Ringel, Y. (2011). Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. Journal of Clinical Gastroenterology, 45(6), 518–525. https://doi.org/10.1097/MCG.0b013e31820ca4d6
- Ducrotté, P., Sawant, P., & Jayanthi, V. (2012). Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World Journal of Gastroenterology, 18(30), 4012–4018. https://doi.org/10.3748/wjg.v18.i30.4012
- Majeed, M., Nagabhushanam, K., Paulose, S., Arumugam, S., & Mundkur, L. (2023). The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore), 102(9), e33109. https://doi.org/10.1097/MD.0000000000033109
- Skrzydło-Radomańska, B., Prozorow-Król, B., Kurzeja-Mirosław, A., et al. (2020). The effectiveness of synbiotic preparation containing Lactobacillus and Bifidobacterium probiotic strains and short chain fructooligosaccharides in patients with diarrhea predominant irritable bowel syndrome—A randomized double-blind, placebo-controlled study. Nutrients, 12(7), 1999. https://doi.org/10.3390/nu12071999
- Simonetto, M., Mandelli, G., Battistini, C., Riboni, F. E., Casiraghi, M. C., & Lucchini, G. (2024). Functional abdominal bloating and gut microbiota: An update. Microorganisms, 12(8), 1669. https://doi.org/10.3390/microorganisms12081669
- Mutuyemungu, E., Singh, M., Liu, S., & Rose, D. J. (2023). Intestinal gas production by the gut microbiota: A review. Journal of Functional Foods, 100, 105367. https://doi.org/10.1016/j.jff.2022.105367
- Pimentel, M., Lin, H. C., Enayati, P., van den Burg, B., Lee, H. R., Chen, J. H., Park, S., Kong, Y., & Conklin, J. (2006). Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. American Journal of Physiology: Gastrointestinal and Liver Physiology, 290(6), G1089–G1095. https://doi.org/10.1152/ajpgi.00574.2004
- Goodoory, V. C., Khasawneh, M., Black, C. J., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2023). Efficacy of probiotics in irritable bowel syndrome: Systematic review and meta-analysis. Gastroenterology, 165(5), 1206–1218. https://doi.org/10.1053/j.gastro.2023.07.018
- Ringel-Kulka, T., Goldsmith, J. R., Carroll, I. M., Barros, S. P., Palsson, O., Jobin, C., & Ringel, Y. (2014). Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain — a randomized clinical study. Alimentary Pharmacology & Therapeutics, 40(2), 200–207. https://doi.org/10.1111/apt.12800
- Sen, S., Mullan, M. M., Parker, T. J., Woolner, J. T., Tarry, S. A., & Hunter, J. O. (2002). Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Digestive Diseases and Sciences, 47(11), 2615–2620. https://doi.org/10.1023/A:1020597001420
- Kalman, D. S., Schwartz, H. I., Alvarez, P., Feldman, S., Pezzullo, J. C., & Krieger, D. R. (2009). A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterology, 9, 85. https://doi.org/10.1186/1471-230X-9-85
- Portincasa, P., Bonfrate, L., Scribano, M. L., Kohn, A., Caporaso, N., Festi, D., Campanale, M. C., Di Ciaula, A., Gasbarrini, A., Corazza, G., & Barbara, G. (2019). Bifidobacterium longum and Lactobacillus rhamnosus on gut microbiota in patients with lactose intolerance and persisting functional gastrointestinal symptoms: A randomised, double-blind, cross-over study. Nutrients, 11(4), 886. https://doi.org/10.3390/nu11040886
- Bonfrate, L., Scribano, M. L., Pecere, S., et al. (2020). Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients. European Journal of Nutrition, 59(7), 3325–3338. https://doi.org/10.1007/s00394-020-02525-7
- Didari, T., Mozaffari, S., Nikfar, S., & Abdollahi, M. (2015). Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology, 21(10), 3072–3084. https://doi.org/10.3748/wjg.v21.i10.3072
- Zamora-Ros, R., Mancilla-Galindo, J., & Pérez-Gaxiola, G. (2025). Efficacy of specific probiotic strains in subtypes of irritable bowel syndrome: Systematic review and meta-analysis of randomized controlled trials. Medicina, 62(1), 89. https://doi.org/10.3390/medicina62010089


Share and get 15% off!
Simply share this product on one of the following social networks and you will unlock 15% off!